Infliximab Versus Vedolizumab in Outpatient Treatment of Immune Checkpoint Inhibitor Colitis

被引：0
|
作者：
Joseph, Joel A. [1 ]
Townsend, Matthew J. [2 ]
Somappa, Aakash K. [1 ]
Sack, Jordan [3 ]
Leboeuf, Nicole R. [4 ]
Sharon, Elad [4 ]
Grover, Shilpa [3 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[4] Harvard Med Sch, Dana Farber Brigham Canc Ctr, Boston, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001029268.66368.a0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S225
引用
收藏
页码：S164 / S165
页数：2
相关论文
共 50 条
  • [21] The colitis may be microscopic, but the diarrhea is not: update on the treatment of microscopic colitis and immune checkpoint inhibitor colitis
    Enwerem, Ngozi Y.
    Yen, Eugene F.
    CURRENT OPINION IN GASTROENTEROLOGY, 2024, 40 (01) : 50 - 59
  • [22] Recurrent Checkpoint Inhibitor Colitis Complicated by Treatment Induced Liver Injury Requiring Vedolizumab Therapy
    Huang, Sarah
    Rahman, Aruni
    Shama, Naureen
    Castillo, Michael
    Mobin, Navim
    Quintero, Samuel
    Bekele, Ezana
    Grosman, Irvin
    Weisberg, Ilan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1717 - S1718
  • [23] Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
    Zhang, Robert S.
    Padegimas, Allison
    Murphy, Kathleen M.
    Evans, Peter T.
    Peters, Carli J.
    Domenico, Christopher M.
    Vidula, Mahesh K.
    Mather, Paul J.
    Cevasco, Marisa
    Cohen, Roger B.
    Carver, Joseph R.
    O'Quinn, Rupal P.
    CARDIO-ONCOLOGY, 2021, 7 (01)
  • [24] Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
    Robert S. Zhang
    Allison Padegimas
    Kathleen M. Murphy
    Peter T. Evans
    Carli J. Peters
    Christopher M. Domenico
    Mahesh K. Vidula
    Paul J. Mather
    Marisa Cevasco
    Roger B. Cohen
    Joseph R. Carver
    Rupal P. O’Quinn
    Cardio-Oncology, 7
  • [25] A case of refractory immune checkpoint inhibitor-induced colitis improved by the treatment with vedolizumab and granulocyte-monocyte apheresis combination therapy
    Ishihara, Hikaru
    Watanabe, Tatsuyuki
    Kumei, Shinsuke
    Kume, Keiichiro
    Yoshikawa, Ichiro
    Harada, Masaru
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2024, 17 (01) : 46 - 51
  • [26] Treatment of immune checkpoint inhibitor-related colitis: a narrative review
    Wang, Shiyang
    Wang, Hanping
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (12) : 7002 - 7014
  • [27] Check this out: treatment paradigms in immune-checkpoint inhibitor colitis
    Kiparizoska, Sara
    Murphy, Megan E.
    Mattar, Mark C.
    CURRENT OPINION IN GASTROENTEROLOGY, 2023, 39 (01) : 43 - 49
  • [28] Use of Vedolizumab in Immune Checkpoint Inhibitor-associated Enterocolitis
    Stone, Molly L.
    Forster, Erin M.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (12) : E147 - E147
  • [29] Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report
    Randhawa, Manreet
    Gaughran, Gregory
    Archer, Christine
    Pavli, Paul
    Morey, Adrienne
    Ali, Sayed
    Yip, Desmond
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2019, 10 (10): : 350 - 357
  • [30] Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study
    Abu-Sbeih, Hamzah
    Ali, Faisal S.
    Alsaadi, Dana
    Jennings, Joseph
    Luo, Wenyi
    Gong, Zimu
    Richards, David M.
    Charabaty, Aline
    Wang, Yinghong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
12345